Naperol Investments Ltd
Incorporated in 1954, National Peroxide Ltd is engaged in Investment and Leasing business[1]
- Market Cap ₹ 497 Cr.
- Current Price ₹ 864
- High / Low ₹ 1,640 / 0.00
- Stock P/E 51.6
- Book Value ₹ 2,055
- Dividend Yield 1.04 %
- ROCE 1.06 %
- ROE 0.95 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.42 times its book value
- Debtor days have improved from 134 to 74.3 days.
Cons
- The company has delivered a poor sales growth of -37.3% over past five years.
- Company has a low return on equity of 0.40% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Investment Company
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 234.22 | 196.29 | 233.22 | 232.97 | 305.55 | 401.50 | 207.91 | 226.29 | 232.17 | 1.89 | 1.92 | 20.14 | 23.73 | |
| 172.95 | 174.36 | 197.33 | 163.29 | 160.82 | 175.38 | 165.64 | 169.80 | 208.91 | 2.13 | 2.53 | 8.42 | 13.45 | |
| Operating Profit | 61.27 | 21.93 | 35.89 | 69.68 | 144.73 | 226.12 | 42.27 | 56.49 | 23.26 | -0.24 | -0.61 | 11.72 | 10.28 |
| OPM % | 26.16% | 11.17% | 15.39% | 29.91% | 47.37% | 56.32% | 20.33% | 24.96% | 10.02% | -12.70% | -31.77% | 58.19% | 43.32% |
| 7.06 | 6.37 | 7.16 | -1.50 | 11.20 | 19.11 | 0.69 | -14.53 | 10.45 | 376.33 | 0.00 | 0.00 | 0.19 | |
| Interest | 0.22 | 4.68 | 5.39 | 2.21 | 0.51 | 0.73 | 2.74 | 12.66 | 8.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 9.73 | 7.21 | 8.96 | 8.93 | 9.19 | 9.23 | 11.23 | 17.50 | 17.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 58.38 | 16.41 | 28.70 | 57.04 | 146.23 | 235.27 | 28.99 | 11.80 | 7.44 | 376.09 | -0.61 | 11.72 | 10.47 |
| Tax % | 33.85% | 61.97% | 37.39% | 33.59% | 34.95% | 34.96% | 40.12% | -76.44% | 31.72% | 0.22% | -40.98% | 9.98% | |
| 38.62 | 6.23 | 17.97 | 37.88 | 95.12 | 153.03 | 17.37 | 20.81 | 5.09 | 375.25 | -0.37 | 10.55 | 9.62 | |
| EPS in Rs | 67.75 | 10.93 | 31.53 | 66.46 | 166.88 | 268.47 | 30.47 | 36.51 | 8.93 | 658.33 | -0.65 | 18.51 | 16.87 |
| Dividend Payout % | 22.33% | 46.15% | 32.00% | 51.61% | 39.29% | 24.42% | 41.38% | 34.54% | 56.48% | 0.15% | 0.00% | 49.05% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -20% |
| 5 Years: | -37% |
| 3 Years: | -56% |
| TTM: | 604% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -9% |
| 3 Years: | 300% |
| TTM: | 882% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -10% |
| 3 Years: | -11% |
| 1 Year: | -47% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 1% |
| 3 Years: | 0% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 | 5.75 |
| Reserves | 200.84 | 203.20 | 214.25 | 368.46 | 503.10 | 609.34 | 480.71 | 582.67 | 531.50 | 551.58 | 1,049.01 | 1,157.81 | 1,165.80 |
| 4.04 | 72.99 | 30.33 | 11.04 | 0.00 | 79.69 | 161.38 | 124.69 | 94.07 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 58.92 | 62.17 | 59.96 | 54.62 | 75.69 | 88.10 | 94.41 | 71.43 | 62.94 | 1.47 | 23.22 | 41.74 | 42.56 | |
| Total Liabilities | 269.55 | 344.11 | 310.29 | 439.87 | 584.54 | 782.88 | 742.25 | 784.54 | 694.26 | 558.80 | 1,077.98 | 1,205.30 | 1,214.11 |
| 116.63 | 187.37 | 179.67 | 178.48 | 169.65 | 165.75 | 372.39 | 342.13 | 337.66 | 0.06 | 0.06 | 0.07 | 0.07 | |
| CWIP | 40.92 | 3.98 | 3.09 | 1.68 | 5.64 | 75.40 | 0.00 | 2.53 | 3.99 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 10.29 | 9.59 | 7.06 | 170.19 | 253.43 | 191.59 | 176.56 | 267.74 | 281.73 | 546.81 | 1,064.72 | 1,189.72 | 1,197.69 |
| 101.71 | 143.17 | 120.47 | 89.52 | 155.82 | 350.14 | 193.30 | 172.14 | 70.88 | 11.93 | 13.20 | 15.51 | 16.35 | |
| Total Assets | 269.55 | 344.11 | 310.29 | 439.87 | 584.54 | 782.88 | 742.25 | 784.54 | 694.26 | 558.80 | 1,077.98 | 1,205.30 | 1,214.11 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.75 | 21.07 | 21.83 | 59.29 | 94.22 | 147.54 | 15.58 | 60.74 | 9.17 | 1.45 | 1.09 | -3.42 | |
| -20.51 | -74.98 | 29.50 | -31.34 | -55.87 | -174.61 | -38.28 | -7.08 | 34.27 | 0.95 | 0.40 | 11.47 | |
| -7.24 | 54.26 | -51.38 | -28.24 | -35.21 | 34.66 | 14.13 | -49.18 | -49.08 | -2.88 | -0.57 | -5.59 | |
| Net Cash Flow | 0.00 | 0.35 | -0.05 | -0.29 | 3.13 | 7.59 | -8.58 | 4.47 | -5.64 | -0.49 | 0.92 | 2.45 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50.66 | 69.10 | 51.11 | 51.97 | 63.61 | 27.81 | 56.62 | 38.45 | 29.68 | 193.12 | 0.00 | 74.30 |
| Inventory Days | 134.14 | 75.95 | 64.53 | 66.26 | 65.32 | 133.93 | 98.14 | 86.78 | 86.85 | 0.00 | ||
| Days Payable | 125.97 | 119.58 | 82.59 | 114.69 | 89.84 | 100.97 | 75.09 | 102.50 | 41.02 | |||
| Cash Conversion Cycle | 58.83 | 25.47 | 33.05 | 3.54 | 39.09 | 60.78 | 79.66 | 22.74 | 75.51 | 193.12 | 0.00 | 74.30 |
| Working Capital Days | 65.61 | 107.14 | 101.01 | 62.40 | 114.93 | 228.62 | 229.82 | 196.80 | 42.20 | -84.97 | -302.27 | 58.54 |
| ROCE % | 29.59% | 8.56% | 13.15% | 21.05% | 32.59% | 39.21% | 4.73% | 5.87% | 1.29% | -0.04% | -0.08% | 1.06% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
4 Nov - Newspaper Publication of Unaudited financial results for quarter and half year ended September 30, 2025.
-
Results For Quarter And Half Year Ended September 30, 2025
3 Nov - Board approved unaudited Q2/H1 results to Sept 30, 2025; H1 total income Rs625.13 lakh; PAT Rs6.71 lakh.
-
Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Unaudited Financial Results For Quarter And Half Year Ended 30.09.2025
3 Nov - Board approved Q2/H1 unaudited results to Sept 30, 2025: H1 total income Rs625.13L, PAT Rs6.71L.
-
Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025
29 Oct - Board meeting on Nov 3, 2025 to approve unaudited Q2 and H1 results for period ended Sep 30, 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Oct - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2025
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Services Offered:[1]
a) Manufacturing, distribution and dealing
of peroxygen chemicals
b) Making long term investments and corporate lending directly and/or through its wholly owned subsidiary viz., the Transferor Company.